Show
Sort by
-
Longevity of the humoral and cellular responses after SARS-CoV-2 booster vaccinations in immunocompromised patients
-
- Journal Article
- A1
- open access
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic : results from the epicovideha registry
-
- Journal Article
- A1
- open access
Multimorbidity and frailty are associated with poorer SARS-CoV-2-related outcomes : systematic review of population-based studies
-
- Journal Article
- A2
- open access
Vaccine hesitancy for the COVID-19 vaccine booster dose among nursing home staff fully vaccinated with the primary vaccination course in Belgium
-
- Journal Article
- A1
- open access
Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic : role of the Belgian National Reference Centre
-
- Journal Article
- A1
- open access
Predicting the next pandemic : VACCELERATE ranking of the World Health Organization's Blueprint for Action to Prevent Epidemics
-
- Journal Article
- A1
- open access
Personal characteristics and transmission dynamics associated with SARS-CoV-2 semi-quantitative PCR test results: an observational study from Belgium, 2021–2022
-
- Journal Article
- A2
- open access
Real-world effectiveness of the heterologous SOBERANA-02 and SOBERANA-Plus vaccine scheme in 2 - 11 years-old children during the SARS-CoV-2 Omicron wave in Cuba : a longitudinal case
-
- Journal Article
- A1
- open access
Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults : the IMCOVAS randomized clinical trial
-
- Journal Article
- A1
- open access
SARS-CoV-2 seropositivity in nursing home staff and residents during the first SARS-CoV-2 wave in Flanders, Belgium